Drug intelligence / Profile preview

autologous platelet rich plasma gel + autologous platelet rich plasma injection

Development stage
Unknown
Modality
Cell Therapies, Recombinant Proteins and Enzymes
Administration
Injectable (local Injection), Topical (application Of Gel)
01

Overview

This is a **combination therapy** consisting of *autologous platelet-rich plasma gel* and *autologous platelet-rich plasma injection*. Both components are derived from a patient's own blood (autologous), processed to concentrate platelets and associated growth factors, and then either injected or applied as a gel to the target tissue. The mechanism centers on delivering high concentrations of platelets, growth factors, and bioactive molecules to injured or diseased tissues, stimulating healing and tissue regeneration via enhanced cell proliferation, angiogenesis, and extracellular matrix synthesis. The gel formulation is typically created by activating the PRP (often with thrombin or calcium chloride), resulting in a semisolid matrix that localizes growth factor release, commonly used for wound coverage. The injection form introduces concentrated PRP directly into tissues or joints to facilitate in situ repair. Indications include chronic wounds (such as diabetic foot ulcers, venous leg ulcers), musculoskeletal injuries, osteoarthritis, dermatological rejuvenation, and additional applications where enhanced tissue repair is sought[1][2][3][4][5][6].

Other names
autologous PRP gel + autologous PRP injectionplatelet-rich plasma gel + platelet-rich plasma injectionplatelet concentrate gel + platelet concentrate injectionPRP gel + PRP injectionautologous platelet gel + autologous PRP injection

Beyond the preview

Go deeper on autologous platelet rich plasma gel + autologous platelet rich plasma injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous platelet rich plasma gel + autologous platelet rich plasma injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call